Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential

Jahr

2018

Autoren

Klistorner A, Chai Y, Leocani L, Albrecht P, Aktas O, Butzkueven H, Ziemssen T, Ziemssen F, Frederiksen J, Xu L, Cadavid D; RENEW MF-VEP Investigators.

Verlag

CNS Drugs. 2018 Dec;32(12):1159-1171.

Link

https://doi.org/10.1007/s40263-018-0575-8

Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential

Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis

COVID-19 and multiple sclerosis: challenges and lessons for patient care

A future of AI-driven personalized care for people with multiple sclerosis

Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons

Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER